GlassScriptPhysician profile
Cristan D Ledbetter
NPI 1427417633
$1,435.07
in general payments reported to CMS, 2019-2025
17 companies · $493 in 2025
The $493 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $184 · 2022: $201 · 2023: $210 · 2024: $346 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,049.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,049.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $246.86 | 2023-2025 | |
| Dexcom, INC. | $143.39 | 2025 | Dexcom G6 Transmitter |
| Otsuka America Pharmaceutical, INC. | $122.79 | 2025 | Rexulti |
| Biohaven Pharmaceutical Holding Company LTD. | $114.77 | 2022 | |
| Amgen INC. | $108.07 | 2024 | Krystexxa |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $103.33 | 2024 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $102.18 | 2025 | Gattex |
| Astrazeneca Pharmaceuticals LP | $100.52 | 2024 | Airsupra |
| Medtronic, INC. | $87.82 | 2023 | Interstim |
| Abbott Laboratories | $86.66 | 2022 | |
| Heron Therapeutics, INC. | $77.26 | 2021 | |
| Stryker Corporation | $34.22 | 2024 | Scopis Ent |
| Bioventus LLC | $26.88 | 2021 | |
| Smith+Nephew, INC. | $25.92 | 2021 | |
| Integra Lifesciences Corporation | $22.24 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $17.21 | 2021 | |
| Acacia Pharma INC | $14.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cristan Ledbetter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.